Coriolis Pharma has announced the opening of its new US headquarters and laboratory, marking the start of operations at the Alexandria Centre for Advanced Technologies (ACAT) in North Carolina's Research Triangle Park (RTP).
The expansion, says the company, will enable it to provide its North American clients with direct access to specialised expertise in formulation and drug product development as well as analytical characterisation of biopharmaceutical products.
The site offers the following three core services:
- Particle analysis and fast track analytics: high precision identification and characterisation of particles and ad hoc non-GMP analytical services
- Formulation development: preclinical, early and late-stage formulation development for liquid and frozen-liquid products
- Drug product development: primary packaging material selection studies and in-depth drug product and filling process characterisation work to support IND/BLA filings.
It is understood that the services will be gradually rolled out throughout 2026, with all features expected to be available by the fourth quarter. Certain fast-track analytical services will commence with live projects in March 2026.
Additionally, all Coriolis services will be accessible through close collaboration with experts at the German headquarters and their global partners. This approach ensures that clients receive comprehensive end-to-end solutions from a single point of contact.
"Opening our lab and US Headquarter[s] in North Carolina is a major leap forward for Coriolis," said Silvia Steyrer‑Gruber, CEO of Coriolis Pharma, "It fuels our mission to empower innovation where it happens."
"The region's scientific excellence, cutting‑edge biotech and manufacturing ecosystem and collaborative energy make it the perfect home for our next chapter.”
John Gabrielson, President of Coriolis Pharma US Inc, added: "We are excited to bring our deep scientific expertise and comprehensive service offerings to the vibrant life science community in North Carolina."
Together with our colleagues in Germany and partners worldwide, we will deliver solutions that meet the highest quality standards—empowering companies in the US to accelerate their development programmes and drive innovation forward.